Pediatric neurosurgical medulloblastoma outcomes in La Paz, Bolivia: How a Lower Middle-Income Country (LMIC) institution in South America compares to the United States

Victor M Lu; Jorge Daniel Brun; Toba N Niazi; Jorge David Brun

doi:10.1007/s11060-024-04664-9

Pediatric neurosurgical medulloblastoma outcomes in La Paz, Bolivia: How a Lower Middle-Income Country (LMIC) institution in South America compares to the United States

J Neurooncol. 2024 Apr 2. doi: 10.1007/s11060-024-04664-9. Online ahead of print.

Authors

Victor M Lu^{1

2

3}, Jorge Daniel Brun⁴, Toba N Niazi^{5

6}, Jorge David Brun⁴

Affiliations

¹ Department of Neurological Surgery, Hospital del Niño "Dr. Ovidio Aliaga Uria", La Paz, Bolivia. victor.lu@jhsmiami.org.
² Department of Neurological Surgery, University of Miami, Jackson Memorial Hospital, Miami, FL, USA. victor.lu@jhsmiami.org.
³ Department of Neurological Surgery, Nicklaus Children's Hospital, Miami, FL, USA. victor.lu@jhsmiami.org.
⁴ Department of Neurological Surgery, Hospital del Niño "Dr. Ovidio Aliaga Uria", La Paz, Bolivia.
⁵ Department of Neurological Surgery, University of Miami, Jackson Memorial Hospital, Miami, FL, USA.
⁶ Department of Neurological Surgery, Nicklaus Children's Hospital, Miami, FL, USA.

PMID: 38563852
DOI: 10.1007/s11060-024-04664-9

Abstract

Background: How pediatric medulloblastoma patients fare in Lower Middle-Income Country (LMICs) in South America is not well understood. Correspondingly, the aim of this study was to summarize the pediatric neurosurgical experience of an institution in La Paz, and compare outcomes to that of a generalized High Income Country (HIC) United States (US) experience.

Methods: A retrospective review of all pediatric neurosurgical medulloblastoma patients at the Children's Hospital of La Paz, Bolivia (Hospital del Niño "Dr. Ovidio Aliaga Uria") between 2014 and 2023 was conducted and compared to a generalized US experience abstracted from the US National Cancer Database (NCDB) and National Inpatient Sample (NIS) databases. Categorical, continuous and survival data were statistically summarized and compared.

Results: A total of 24 pediatric medulloblastoma patients underwent neurosurgical treatment at the Hospital del Niño. In this La Paz cohort, there were 15 (63%) males and 9 (38%) females, with a mean age of 5.6 years old at diagnosis. The majority of patients underwent subtotal resection (STR, 79%), while the remaining patients underwent biopsy only. Ten (42%) patients expired during their hospitalization, and mean length of stay overall was 39 days. Only 8 (33%) patients received adjuvant treatment after surgery. Median overall survival from diagnosis in the La Paz cohort was 1.9 months. Compared to the US databases, the La Paz cohort experienced significantly more emergency room admissions for surgery, less gross total resection, more STR, more return to operating room for ventriculoperitoneal shunting, more bacteremia, more tracheostomy procedures, more percutaneous gastrostomy placements, longer lengths of stay, less adjuvant chemotherapy, less radiation therapy, shorter follow-up, and ultimately, significantly shorter overall survival (all P < 0.050).

Conclusions: Pediatric neurosurgical medulloblastoma outcomes at the Children's Hospital of La Paz, Bolivia are significantly inferior to that of a generalized US experience. Future research is required to identify institution- and country-specific initiatives to improve discrepancies between institutions in LMICs in South America compared to HICs.

Keywords: Bolivia; LMIC; La Paz; Medulloblastoma; Neurosurgery; Pediatric; South America.